Vertex Pharmaceuticals, Inc. (VRTX)
443.64
-5.89
(-1.31%)
USD |
NASDAQ |
Jan 15, 10:53
Vertex Pharmaceuticals Market Cap: 112.56B for Jan. 15, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Pfizer Inc. | 144.64B |
| Amgen, Inc. | 175.56B |
| Eli Lilly & Co. | 916.73B |
| Merck & Co., Inc. | 272.72B |
| Regeneron Pharmaceuticals, Inc. | 78.69B |
Market Cap Related Metrics
| PE Ratio | 31.27 |
| PS Ratio | 9.796 |
| Price to Book Value | 6.499 |
| Price to Free Cash Flow | 34.45 |
| Price | 443.64 |
| Earnings Yield | 3.20% |
| Operating PE Ratio | 25.39 |
| Normalized PE Ratio | 28.35 |